On Tuesday, Gossamer Bio Inc (NASDAQ: GOSS) opened lower -1.64% from the last session, before settling in for the closing price of $0.86. Price fluctuations for GOSS have ranged from $0.50 to $1.60 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 76.06% at the time writing. With a float of $174.03 million, this company’s outstanding shares have now reached $226.60 million.
Considering the fact that the conglomerate employs 135 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 97.34%, operating margin of -56.03%, and the pretax margin is -60.96%.
Gossamer Bio Inc (GOSS) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Gossamer Bio Inc is 23.20%, while institutional ownership is 57.01%. The most recent insider transaction that took place on Jun 24 ’24, was worth 1,260. In this transaction Chief Medical Officer of this company sold 1,908 shares at a rate of $0.66, taking the stock ownership to the 196,891 shares. Before that another transaction happened on Jun 21 ’24, when Company’s President & CEO bought 372,000 for $0.67, making the entire transaction worth $250,282. This insider now owns 5,408,073 shares in total.
Gossamer Bio Inc (GOSS) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 76.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.20% during the next five years compared to 11.99% growth over the previous five years of trading.
Gossamer Bio Inc (NASDAQ: GOSS) Trading Performance Indicators
Check out the current performance indicators for Gossamer Bio Inc (GOSS). In the past quarter, the stock posted a quick ratio of 6.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.33, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Gossamer Bio Inc (GOSS)
Compared to the last year’s volume of 1.49 million, its volume of 0.88 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 31.99%. Additionally, its Average True Range was 0.07.
During the past 100 days, Gossamer Bio Inc’s (GOSS) raw stochastic average was set at 40.64%, which indicates a significant decrease from 40.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 120.75% in the past 14 days, which was higher than the 69.55% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8238, while its 200-day Moving Average is $0.8871. Nevertheless, the first resistance level for the watch stands at $0.8758 in the near term. At $0.9078, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.9355. If the price goes on to break the first support level at $0.8161, it is likely to go to the next support level at $0.7884. Should the price break the second support level, the third support level stands at $0.7564.
Gossamer Bio Inc (NASDAQ: GOSS) Key Stats
There are currently 226,604K shares outstanding in the company with a market cap of 194.88 million. Presently, the company’s annual sales total 0 K according to its annual income of -179,820 K. Last quarter, the company’s sales amounted to 9,480 K and its income totaled -30,800 K.
